Menu

Image of the Day: Tadpole Prism

Scientists are making use of Xenopus tadpoles to study autism risk genes. 

Nov 3, 2017
The Scientist Staff, The Scientist Staff

A confocal tiled image of a Xenopus laevis tadpole, showing the neural tract and brain (green), muscle (red), and cell nuclei (blue). HELEN WILLSEY, UNIVERSITY OF CALIFORNIA, SAN FRANCISCOScientists are using tadpoles to study the roles of genes associated with autism spectrum disorder during neurodevelopment. In this Xenopus laevis youngster, the neural system and brain has been stained green (using beta tubulin as a neuronal marker), the muscle stained red (using phalloidin), and cell nuclei stained blue (using DAPI, a blue-fluorescent DNA stain). 

April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Marketplace

Sponsored Product Updates

Getting More Consistent Results by Knowing the Quality of Your Protein
Getting More Consistent Results by Knowing the Quality of Your Protein
Download this guide from NanoTemper to learn how to identify and evaluate the quality of your protein samples!
Myth Busting: The Best Way to Use Pure Water in the Lab
Myth Busting: The Best Way to Use Pure Water in the Lab
Download this white paper from ELGA LabWater to learn about the role of pure water in the laboratory and the advantages of in-house water purification!
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu Corporation announces the release of the Nexera Ultra High-Performance Liquid Chromatograph series, incorporating artificial intelligence as Analytical Intelligence, allowing systems to detect and resolve issues automatically. The Nexera series makes lab management simple by integrating IoT and device networking, enabling users to easily review instrument status, optimize resource allocation, and achieve higher throughput.
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
Increasing accuracy and reducing cost barriers, IDT’s innovative system delivers simple and cost-effective amplicon sequencing